The invention is based on the finding that clinico-chemical blood parameters can be determined using not only blood serum but also blood plasma. Therefore, freshly taken blood samples, which are mixed with a specific thrombin inhibitor, can be used for determining both clinico-chemical parameters and haematological parameters. The clinico-chemical parameters can thus be determined using blood plasma, a separation of coagulable components not being required any more.
